Recommendation (n = 101) | No Recommendation (n = 1006) | P Value | |
---|---|---|---|
Age (years) | <.0001 | ||
<65 | 40.6% | 76.8% | |
65–75 | 38.6% | 17.4% | |
>75 | 20.8% | 5.8% | |
Diagnosis | |||
COPD | 7.9% | 3.6% | .0332 |
Diabetes | 48.5% | 6.4% | <.0001 |
Hypertension | 84.2% | 27.1% | <.0001 |
Vascular disease | 26.7% | 5.4% | <.0001 |
Heart failure | 5% | 1% | .001 |
Depression | 22.8% | 14.7% | .0326 |
eGFR <45 mL/min | 9.9% | 2.5% | <.0001 |
Hemoglobin A1c >7.9% | 11.9% | 0.9% | <.0001 |
Stage 1 or stage 2 hypertension* | 19.8% | 5.6% | <.0001 |
Items on medication list | <.0001 | ||
<3 | 2% | 34.2% | |
3–5 | 9.9% | 25.7% | |
6–9 | 25.7% | 21% | |
≥9 | 61.4% | 19.1% |
↵* Stage 1 hypertension = blood pressure 140–159/90–99 mmHg; stage 2 hypertension = blood pressure ≥160/100 mmHg.
COPD, chronic obstructive pulmonary disease; eGFR, estimated glomerular filtration rate.